1. Introduction
===============

The concurrent existence of pituitary adenoma and meningioma is extremely rare and even rarer in patients with no previous known risk factors for either tumour. Here, we present a first reported case of synchronous non-functioning pituitary adenoma with suprasellar and olfactory groove meningiomas in a patient without previous irradiation.

2. Case Presentation
====================

A coexistence of pituitary adenoma with suprasellar and olfactory groove meningiomas was discovered in a 65-year-old woman on MRI performed following visual symptoms and an episode of self-resolving vertigo. She had no previous cranial irradiation or family history of inherited conditions. Visual acuity was normal but visual field examination revealed patchy defects inconsistent with compression of the optic apparatus. She had no clinical features of endocrinopathy, frontal lobe, or neurocutaneous syndromes.

Contrast-enhanced MRI demonstrated a large 16×13×20 mm pituitary lesion consistent with pituitary macroadenoma and, immediately adjacent to it, a 15×13×13 mm homogenous enhancing lesion arising from tuberculum sella compressing the optic apparatus ([Figure 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}). A third small 6×5 mm, homogenously enhancing lesion with a dural tail was found along the olfactory groove, consistent with an olfactory groove meningioma (OGM) ([Figure 2](#F2){ref-type="fig"}). Preoperative pituitary hormonal evaluation was normal: follicle-stimulating hormone (FSH) of 30.2 IU/L (reference range: \<100 IU/L in postmenopausal women), thyroid stimulating hormone (TSH) of 2.15 mIU/L (reference range: 0.35--5.50 mIU/L), luteinizing hormone (LH) of 13.2 IU/L (reference range: \<62 IU/L in postmenopausal women), growth hormone (GH) of 1.2 μg/L (reference range: \<5μg/L), adrenocorticotrophic hormone (ACTH) of 22 pg/mL (reference range: \<46 pg/mL), prolactin (PRL) of 18.8 μg/L (reference range: \<25 μg/L).

![Preoperative T1-weighted postcontrast coronal MRI revealing a homogenously enhancing suprasellar meningioma (asterisk) and an adjacent pituitary macroadenoma of variable intensity in the pituitary region (straight black arrow). The suprasellar meningioma extends into the interhemispheric fissure.](BCN-7-361-g001){#F1}

![Preoperative T1-weighted postcontrast sagittal MRI image revealing a smaller olfactory groove meningioma with dural tail (straight white arrow) noted in the sagittal section along with suprasellar meningioma (asterisk) and the pituitary macroadenoma (straight black arrow).](BCN-7-361-g002){#F2}

3. Treatment Protocol
=====================

After discussion with the patient, the decision was made to resect the 2 sellar region tumours (because of their size) to decompress the optic apparatus. Meanwhile, the smaller asymptomatic OGM was managed conservatively with serial imaging.

An extended endoscopic transsphenoidal approach (EETS) for resection of both pituitary macroadenoma and the suprasellar meningioma was performed uneventfully. The soft, grey-pink pituitary macroadenoma was encountered along with the avascular and firm suprasellar meningioma displacing the optic nerves laterally ([Figure 3](#F3){ref-type="fig"}). Total macroscopic clearance was achieved ([Figure 4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}). Postoperative visual field testing and hormonal evaluation studies were normal.

![Intraoperative photograph demonstrating that the suprasellar meningioma (asterisk) is first dissected off with an endonasal probe (P), while the overlying anterior cerebral arteries (black arrowheads), optic chiasm (O), and pituitary macroadenoma (straight black arrow) are visible.](BCN-7-361-g003){#F3}

![Postoperative T1-weighted postcontrast sagittal MRI revealing persistent olfactory groove meningioma with no change in size. Pituitary macroadenoma and the adjacent suprasellar meningioma were resected with no residual tumour.](BCN-7-361-g004){#F4}

![Postoperative T1-weighted postcontrast coronal MRI revealing absence of pituitary adenoma and suprasellar meningioma, which have been resected.](BCN-7-361-g005){#F5}

Based on histopathology report, the pituitary lesion possessed nests of monotonous cells with round nuclei and amphophilic cytoplasm, all of them stained negatively on immunoperoxidase to pituitary hormones (LH, FSH, GH, TSH, PRL, ACTH) confirming the diagnosis of non-functioning pituitary adenoma (NFPA) ([Figure 6](#F6){ref-type="fig"}). The second suprasellar tumour was composed of spindle cells with elongated oval nuclei arranged irregularly and in whorls, consistent with WHO grade 1 meningioma ([Figure 7](#F7){ref-type="fig"}).

![High-power (100x) hematoxylin and eosin (H&E)-staining micrograph showing nests of uniform cells separated by a fine vascular network consistent with pituitary adenoma. The uniform cells contain round nuclei, stippled chromatin and delicately vesicular amphophilic cytoplasm.](BCN-7-361-g006){#F6}

![High-power (100x) hematoxylin and eosin (H&E)-stained micrograph demonstrating a section with spindle cells containing elongated, oval nuclei, some of which contain nuclear pseudoinclusions and finely vesicular amphophilic cytoplasm, arranged in an irregular whorl-like pattern, consistent with benign meningioma.](BCN-7-361-g007){#F7}

4. Discussion
=============

Although the association of meningioma and pituitary adenoma in patients without previous irradiation has been reported, it is extremely rare ([@B1]; [@B6]; [@B7]; [@B9]). Most of the cases include growth-hormone-producing adenoma associated with a single meningioma ([@B1]; [@B7]). This association has been theorised to be due to persistently elevated growth-hormone inducing and stimulating growth of arachnoid cap cells into meningioma ([@B7]).

Here, we present a case of NFPA with concurrent suprasellar and olfactory meningiomas in a radiation-naïve patient. To our knowledge, this is the first such reported case. [@B1] observed a NFPA with concurrent meningiomas in sphenoid ridge and parasellar region in an elderly lady. However, the meningiomas were not resected and it is unclear if the patient has previous cranial irradiation.

Fifty percent of NFPA cases display growth with long term follow-up ([@B2]). On the other hand, meningiomas can have variable growth rate: some plateau in size or grow very slowly ([@B10]). Being mostly benign, NFPAs or meningiomas can be managed conservatively with serial imaging or surgical resection.

The presence of multiple meningiomas concurrent with a pituitary macroadenoma in our case presented a challenge in management strategies. EETS often requires the collaboration between ENT and neurosurgeons. It is commonly utilised to approach pituitary region tumours for its excellent visualisation and access to tumours whilst avoiding the need for craniotomy and lowering perioperative complication rates ([@B8]; [@B4]). This is further supported by reports of EETS for resection of synchronous suprasellar meningioma and pituitary adenoma in a single approach with success, when traditionally 2 separate operations would have been required for dual tumours in the parasellar region ([@B9]; [@B6]).

Although EETS is increasingly accepted for resection of anterior skull base meningiomas with gross total rate of resection at 63%--67%, its use in resecting a concurrent OGM together with the pituitary region tumours has not been reported ([@B3]; [@B5]). We believe that such procedure in our patient would have necessitated a much more extensive approach with higher surgical complication risk, including cerebrospinal fluid leaks and inevitable anosmia ([@B3]). Our decision to manage the OGM conservatively was supported by a review by [@B10] concluding the size of meningioma at diagnosis being a predictor for its growth pattern, with only 2% of untreated meningiomas smaller than 20 mm in size going on to develop new symptoms in 5-year-period compared to 42% in larger meningiomas.

In conclusion, this is the first reported case, to our knowledge, of pituitary adenoma with concurrent olfactory groove and tuberculum sella meningiomas.
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